<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25496" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Myotonic Dystrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vydra</surname>
            <given-names>Darrell G.</given-names>
          </name>
          <aff>UT Health San Antonio</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rayi</surname>
            <given-names>Appaji</given-names>
          </name>
          <aff>Charleston Area Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Darrell Vydra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Appaji Rayi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25496.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Myotonic dystrophy is a rare progressive disorder that universally presents with weakness. In addition to musculoskeletal weakness, cardiac conduction defects and early cataracts are common. There are two distinct forms of myotonic dystrophy: DM1 and DM2. Treatment involves an interprofessional approach managing the medical complications associated with myotonic dystrophy as there is no treatment targeting the disorder itself. This activity reviews the evaluation and management of myotonic dystrophy and highlights the role of the interprofessional teams in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of myotonic dystrophy and its associated medical conditions and management.</p></list-item><list-item><p>Outline the appropriate evaluation of the different forms of myotonic dystrophy.</p></list-item><list-item><p>Review the associated medical comorbidities associated with myotonic dystrophy.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and treatment strategies to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25496&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25496">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25496.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Myotonic dystrophy (DM) is considered a subgroup of myopathy and the most common type of muscular dystrophy that begins in adulthood. There are two major forms recognized based on clinical and molecular presentation: Myotonic dystrophy type I (DM1), known as Steinert disease, and myotonic dystrophy type II (DM2), or proximal myotonic myopathy which is a milder variety of DMI. These are progressive, multisystem genetic disorders. Clinical presentation is diverse and can range from asymptomatic electrical myotonia to severe weakness and disability, including cardiac conduction defects, infertility, cataracts, and insulin resistance.<xref ref-type="bibr" rid="article-25496.r1">[1]</xref> A congenital form of DM type 1 is associated with an apparent developmental disability. Myotonia is characterized by impaired relaxation of muscles after voluntary contraction due to repetitive depolarization of the muscle membrane. Myotonia, due to myotonic dystrophy, improves with repeated exercise and is worsened by exposure to cold.</p>
      </sec>
      <sec id="article-25496.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Myotonias are inherited disorders acquired in an autosomal dominant fashion. Both DM1 and DM2 are caused by an expansion of DNA tandem repeats, which results in an RNA gain of function mutation.<xref ref-type="bibr" rid="article-25496.r1">[1]</xref> DM1 is caused by&#x000a0;expansion of cytosine-thymine-guanine (CTG) repeat in the 3&#x02019;-untranslated region of the DM1 protein kinase (DMPK) gene on chromosome 19q13.3.<xref ref-type="bibr" rid="article-25496.r2">[2]</xref> DM2 results from the expansion of cytosine-cytosine-thymine-guanine (CCTG) tetranucleotide repeat located in the intron of the CCHC-type zinc finger nucleic acid-binding protein (CNB or ZNF9) gene on chromosome 3q21.3.<xref ref-type="bibr" rid="article-25496.r3">[3]</xref></p>
      </sec>
      <sec id="article-25496.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Myotonic dystrophy is the most common muscular dystrophy in people of European ancestry.<xref ref-type="bibr" rid="article-25496.r4">[4]</xref> DM1 is more common than DM2, and globally DM has an incidence of 1 per 3000 though some regions, such as Quebec, have demonstrated an incidence of 1 per 500.<xref ref-type="bibr" rid="article-25496.r5">[5]</xref><xref ref-type="bibr" rid="article-25496.r6">[6]</xref><xref ref-type="bibr" rid="article-25496.r7">[7]</xref></p>
      </sec>
      <sec id="article-25496.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of DMI is related to the number of CTG repeats, with more repeats correlating with more severe disease. Those with less than 35 repeats are considered normal, and those that manifest with clinical symptoms typically have greater than 50. Maternal transmissions will often result in&#x000a0;greater CTG expansion.<xref ref-type="bibr" rid="article-25496.r6">[6]</xref> Additionally, the newly expanded alleles have a bias for further expansions that leads to the genetic phenomenon of anticipation when transmitted from one generation to the next. The symptoms manifest at an earlier age with each successive generation due to this phenomenon. Secondly, new alleles with varied repeat sizes are continuously generated in non-dividing cells of skeletal muscle, heart, and brain. Skeletal muscles typically have more than 2,000 expansion repeats by age 20 and 4,000 by age 40, and a&#x000a0;proposed mechanism of symptom progression is related to the age-dependent growth of the CTG repeats.<xref ref-type="bibr" rid="article-25496.r4">[4]</xref> In DM2, 75 or longer repeats are considered pathogenic.<xref ref-type="bibr" rid="article-25496.r8">[8]</xref> Unlike DM1, in DM2, there is no clear correlation between the length of the CCTG expansion and clinical severity. However, similar to DM1, CTG repeats continue with age.</p>
      </sec>
      <sec id="article-25496.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Muscle biopsy demonstrates irregularity in muscle fiber size, rows of internal nuclei, muscle fibrosis, and myofibril orientation that is perpendicular to the muscle fiber. Type I fiber atrophy can be seen along with increased intrafusal fibers.<xref ref-type="bibr" rid="article-25496.r6">[6]</xref></p>
      </sec>
      <sec id="article-25496.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Myotonic dystrophy has a spectrum of clinical history and presentation, based on the number of CTG repeats present in the individual. This is a multisystem disorder that affects somatic and smooth muscles, and ophthalmological, cardiovascular, endocrine, and central nervous systems as well. It can range in presentation from lethal in infancy to being mild with the first presentation in late adulthood. DM1 is classically divided into three types: (1) congenital, (2) mild, and (3) classic. There is an additional subtype that typically presents in childhood, around the age of 10 as well. DM2 is a milder form than classic DM1.</p>
        <p>
<bold>Congenital Myotonic Dystrophy (CDM)</bold>
</p>
        <p>The congenital form presents in about 15% of cases, with fetal-onset involvement of muscle and the CNS and typically is seen in those with more than 1,000 repeats.<xref ref-type="bibr" rid="article-25496.r4">[4]</xref> Prenatal manifestations of CDM may include&#x000a0;reductions in&#x000a0;fetal movement and polyhydramnios. Additionally, equinovarus&#x000a0;and&#x000a0;ventriculomegaly can be appreciated on fetal ultrasound.<xref ref-type="bibr" rid="article-25496.r9">[9]</xref> The neonatal mortality rate is around 18%.<xref ref-type="bibr" rid="article-25496.r4">[4]</xref> Those who survive into childhood or adulthood typically exhibit a characteristic tented appearance of the upper lip that results from facial diplegia. <xref ref-type="bibr" rid="article-25496.r10">[10]</xref> Other features include marked dysarthria and expressive aphasia. Hypotonia, rather than myotonia, is a hallmark of congenital DMI since myotonia or electrical myotonia are seldom present in the first year of life. Thus respiratory involvement is frequently seen and is the principal cause of death during this period.<xref ref-type="bibr" rid="article-25496.r10">[10]</xref></p>
        <p>
<bold>Mild Myotonic Dystrophy</bold>
</p>
        <p>The mild form of DM1 or the oligosymptomatic form is associated with mild weakness, myotonia, and cataracts that begin between 20 to 70 years (typically after age 40 years).<xref ref-type="bibr" rid="article-25496.r4">[4]</xref> These patients usually have normal lifespans, and their CTG repeat size ranges between 50 and 150.</p>
        <p>
<bold>Classic Myotonic Dystrophy</bold>
</p>
        <p>The classic form of DM1 usually manifests during 2, 3, or 4 decades of life. Myotonia is the primary initial symptom.<xref ref-type="bibr" rid="article-25496.r4">[4]</xref>&#x000a0;It is characterized by a &#x0201c;warm-up phenomenon&#x0201d; upon examination where it appears more pronounced after rest and improves with muscle activity.<xref ref-type="bibr" rid="article-25496.r11">[11]</xref> Distal muscle weakness is the predominant symptom in classic DM1.<xref ref-type="bibr" rid="article-25496.r6">[6]</xref> This leads to impairment of fine motor tasks involving the hands and impaired gait due to foot drop. The classic form also presents with the characteristic &#x0201c;myopathic face&#x0201d; or &#x0201c;hatchet face&#x0201d; due to weakness and wasting of the facial, levator palpebrae, and masticatory muscles.<xref ref-type="bibr" rid="article-25496.r12">[12]</xref> As opposed to DM2, hearing loss is not frequently encountered. Cardiac conduction abnormalities are often seen. Lifespan is reduced compared to average.</p>
        <p>
<bold>Childhood Myotonic Dystrophy</bold>
</p>
        <p>The childhood (infantile) subset of DM1 typically presents around age 10. It might even be undiagnosed due to a lack of neurological symptoms unless there is a prior positive family history of DM. Initial symptoms include learning difficulties and psychosocial problems.<xref ref-type="bibr" rid="article-25496.r13">[13]</xref> Dysarthria and hand muscle myotonia may be prominent features and might exacerbate learning difficulties. Cardiac conduction abnormalities may be diagnosed as early as age 10.</p>
        <p>
<bold>Myotonic Dystrophy Type II</bold>
</p>
        <p>DM2 typically manifests in adulthood (median age 48 years) and has a variable presentation.<xref ref-type="bibr" rid="article-25496.r14">[14]</xref> Some physical examination findings include early-onset cataracts (younger than 50 years), varying grip myotonia, proximal muscle weakness or stiffness, hearing loss, and myofascial pain.<xref ref-type="bibr" rid="article-25496.r15">[15]</xref> Weakness and/or myalgias are the most common initial presenting symptom and are seen in 50% of patients.<xref ref-type="bibr" rid="article-25496.r14">[14]</xref> DM2 presents mostly with axial and proximal muscle weakness that affects the neck flexors, long finger flexors, hip flexors, and hip extensors in contrast to DM1 that typically manifests as distal muscle weakness.<xref ref-type="bibr" rid="article-25496.r15">[15]</xref> Pain is one of the primary complaints in DM2 and is described as abdominal, musculoskeletal, and exercise-related pain. It typically fluctuates and is sometimes misdiagnosed as fibromyalgia.<xref ref-type="bibr" rid="article-25496.r16">[16]</xref></p>
      </sec>
      <sec id="article-25496.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Myotonic dystrophy should be suspected in patients with symptoms of weakness, a suspected family history DM, and characteristic physical exam findings. Genetic testing for CTG repeats has replaced other modalities in the diagnosis of DM.&#x000a0;Other diagnostic testing modalities may often be obtained prior to genetic testing and involves serum creatinine kinase, hepatobiliary function testing, muscle biopsies, and electrocardiographic findings for cardiomyopathy.&#x000a0;</p>
        <p>
<bold>Genetic testing</bold>
</p>
        <p>Genetic testing is performed to reveal the presence of an expanded CTG repeat in the dystrophia myotonica protein kinase (DMPK) gene and establish a definitive diagnosis. Alleles containing 5 to 34 CTG repeats are normal, and between 35 and 50 are mutable normal alleles (permutation alleles). Demonstrating full penetrance alleles of greater than 50 CTG repeats confirms the diagnosis associated with clinical manifestations. If this testing is negative and clinical suspicion is high, genetic testing specific for CCTG repeat in the ZNF9 (CNBP- Cellular nucleic acid-binding protein) gene should be pursued.<xref ref-type="bibr" rid="article-25496.r17">[17]</xref>&#x000a0;CCTG repeats over 75 is typical for clinical manifestation of DM2.<xref ref-type="bibr" rid="article-25496.r14">[14]</xref></p>
        <p>
<bold>Serum Creatine Kinase</bold>
</p>
        <p>In patients with mild disease, it may be mildly elevated but is typically normal.</p>
        <p>
<bold>Hepatobiliary Function</bold>
</p>
        <p>Elevations in the hepatobiliary enzymes alkaline phosphatase, gamma-glutamyl transferase (GGT), serum aspartate aminotransferase, and serum alanine aminotransferase can be seen in 30% to 50% of patients. Elevations do not correlate with the severity of muscle weakness, disease duration, or serum levels of creatine kinase.<xref ref-type="bibr" rid="article-25496.r18">[18]</xref></p>
        <p>
<bold>Electrodiagnostic Testing</bold>
</p>
        <p>Electrodiagnostic (EDX) testing has been the modality of choice for diagnosis prior to molecular testing. It has the capability to diagnose patients&#x000a0;who are clinically asymptomatic or have subtle findings.<xref ref-type="bibr" rid="article-25496.r19">[19]</xref> Motor nerve conduction studies (NCS) show decreased amplitude with normal latency and normal conduction velocities. Sensory nerve conduction studies are typically normal. Electromyography (EMG) typically has normal insertional activity. Early recruitment with short duration and small amplitudes&#x000a0;motor unit potentials are observed. Myotonic discharges are highly specific and&#x000a0;consist of spontaneous discharges that have a waxing and waning of amplitude and frequency, typically from around 150/second to 20/second.<xref ref-type="bibr" rid="article-25496.r20">[20]</xref><xref ref-type="bibr" rid="article-25496.r21">[21]</xref> It is shown that evaluating distal muscles is more sensitive for detecting myotonic discharges than proximal muscles.<xref ref-type="bibr" rid="article-25496.r21">[21]</xref></p>
        <p>
<bold>Overview of Electrodiagnostic Findings of Myotonia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sustained runs of positive sharp waves</p>
          </list-item>
          <list-item>
            <p>Trains of negative spikes</p>
          </list-item>
          <list-item>
            <p>Amplitudes and frequency that wax and wane producing a sound comparable to a dive bomber. This occurs due to rapid, spontaneous fluctuations in the membrane potential of muscle fibers.</p>
          </list-item>
        </list>
        <p>
<bold>Muscle Biopsy</bold>
</p>
        <p>Muscle biopsy typically reveals a morphological picture of a myopathy. The majority of biopsy findings are seen in proximal muscle groups, most notably in the biceps brachii and tibialis anterior muscles.<xref ref-type="bibr" rid="article-25496.r22">[22]</xref> Type I fiber atrophy can be seen in early disease, along with type II fiber hypertrophy. Additional findings include irregularity in muscle fiber size, rows of internal nuclei, muscle fibrosis, and myofibril orientation that is perpendicular to the muscle fiber.</p>
      </sec>
      <sec id="article-25496.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no curative treatment for DM. Thus, maximizing health and functional independence is the goal of supportive management. This is geared towards monitoring and treating all the medical issues associated with DM.</p>
        <p>
<bold>Medical Treatment</bold>
</p>
        <p><italic toggle="yes">Cardiovascular</italic>: Cardiac monitoring with a 12-lead electrocardiogram should be performed in all patients once diagnosed with DM and annually to monitor cardiac conduction disturbances. Baseline cardiac imaging should be performed and serially every 1 to 5 years thereafter.<xref ref-type="bibr" rid="article-25496.r23">[23]</xref></p>
        <p><italic toggle="yes">Pulmonary</italic>: Obtaining a baseline and serial pulmonary function testing to monitor for neuromuscular respiratory failure.<xref ref-type="bibr" rid="article-25496.r24">[24]</xref></p>
        <p><italic toggle="yes">Daytime somnolence and obstructive sleep apnea:&#x000a0;</italic>Evaluate for sleep apnea and prescribe continuous positive airway pressure (CPAP) if required. Neurostimulants such as methylphenidate can be considered for excessive sleepiness.</p>
        <p><italic toggle="yes">Ocular involvement:&#x000a0;</italic>Annual eye exam that includes slit-lamp examination is recommended annually. Surgical removal of cataracts that impair vision and function.<xref ref-type="bibr" rid="article-25496.r24">[24]</xref></p>
        <p><italic toggle="yes">Obstetrics and gynecology care:&#x000a0;</italic>A high-risk obstetrics evaluation is indicated for patients who are pregnant or considering pregnancy due to the risk of miscarriage, preterm delivery, and respiratory difficulties during pregnancy.</p>
        <p><italic toggle="yes">Endocrine issues:</italic> These patients are at increased risk of diabetes mellitus from insulin resistance; thus, a baseline and annual fasting blood glucose and hemoglobin A1C are recommended. Screening for hypothyroidism is also required. Since primary hypogonadism and erectile dysfunction are commonly seen in men with DM1, questioning about erectile dysfunction is suggested and accordingly treated if low testosterone is detected on further testing.</p>
        <p><italic toggle="yes">Myotonia:&#x000a0;</italic>Medications that reduce sustained myotonia are used and include sodium channel blockers such as mexiletine, tricyclic antidepressants, benzodiazepines, or calcium antagonists. Sodium channel blockers are contraindicated in those with second and third-degree heart block.</p>
        <p>
<bold>Therapy</bold>
</p>
        <p>Physical and occupational therapy is recommended for strengthening weakened muscles, evaluation for orthotics, and durable medical equipment needs. Speech-language pathology (SLP) is required for dysphagia and swallowing studies or dysarthria as indicated. SLP is also utilized for intellectual disabilities and learning strategies.</p>
      </sec>
      <sec id="article-25496.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Schwartz&#x02013;Jampel Syndrome</bold>
</p>
        <p>This is a rare condition caused by a loss of function mutation of the heparan sulfate proteoglycan 2 gene (HSPG2). Unlike DM, there is no warm-up phenomenon of the myotonia. Additionally, during nerve conduction studies, the myotonic discharges lack the waxing and waning in amplitude and frequency.<xref ref-type="bibr" rid="article-25496.r25">[25]</xref></p>
        <p>
<bold>Hyperkalemic Periodic Paralysis (HPP)</bold>
</p>
        <p>HPP is an autosomal dominant muscle sodium channelopathy that is illustrated by episodic attacks of muscle weakness. It is due to a mutation of the SCN4A protein of skeletal muscle sodium channels located on chromosome 17q23. The attacks characteristically manifest during the first decade of life and typically last less than one hour.<xref ref-type="bibr" rid="article-25496.r26">[26]</xref> Skipping meals, foods with high potassium content, cold temperatures, or resting post-exercise can exacerbate the attacks. Administering 2 to 10 g of potassium under supervision can be&#x000a0;done while performing serial strength examinations every 10 to 20 minutes,&#x000a0;which should elicit an&#x000a0;attack of weakness.<xref ref-type="bibr" rid="article-25496.r27">[27]</xref></p>
        <p>
<bold>Paramyotonia Congenita (PC)</bold>
</p>
        <p>PC presents&#x000a0;with paradoxical myotonia, which is made worse by repetitive muscle contractions and exercise. It also demonstrates increased myotonia with decreased muscle temperature.<xref ref-type="bibr" rid="article-25496.r28">[28]</xref> The etiology is due to mutations in the sodium voltage-gated channel alpha subunit 4 gene (SCN4A).<xref ref-type="bibr" rid="article-25496.r29">[29]</xref>&#x000a0;PC typically presents during the first decade of life and commonly affects the facial and upper extremities muscles, with the lower extremities less affected.&#x000a0;</p>
        <p>
<bold>Myotonia Congenita</bold>
</p>
        <p>Myotonia congenita is an inheritable disorder of the chloride voltage-gated channel 1 gene (CLCN1) on chromosome 7q35, which encodes the chloride channel within human skeletal muscle. It has an autosomal recessive (Becker disease) and autosomal dominant (Thomsen disease) inheritance pattern. The autosomal form tends to be more severe.<xref ref-type="bibr" rid="article-25496.r30">[30]</xref></p>
        <p>
<bold>Conditions with Electrical Myotonia without Clinical Myotonia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Myotubular myopathy</p>
          </list-item>
          <list-item>
            <p>Acid maltase deficiency</p>
          </list-item>
          <list-item>
            <p>Debrancher deficiency</p>
          </list-item>
          <list-item>
            <p>Inflammatory myopathies</p>
          </list-item>
          <list-item>
            <p>Hypothyroid myopathy</p>
          </list-item>
          <list-item>
            <p>Chloroquine myopathy</p>
          </list-item>
          <list-item>
            <p>Statin myopathy</p>
          </list-item>
          <list-item>
            <p>Cyclosporine myopathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25496.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of myotonic dystrophy correlates with the age of onset and the size of expansion of CTG repeats. Earlier age of onset of symptoms and a greater number of CTG repeats are linked with poorer functional outcomes and reduced survival rates.<xref ref-type="bibr" rid="article-25496.r31">[31]</xref> Up to 50% of individuals with DM1 tend to be partially or wheelchair dependent prior to death.<xref ref-type="bibr" rid="article-25496.r32">[32]</xref> Those with DM2 have a milder course and are typically independent of durable medical equipment or assistive devices for mobility. The leading cause of mortality in DM is neuromuscular-associated respiratory&#x000a0;failure, followed by cardiovascular complications.<xref ref-type="bibr" rid="article-25496.r33">[33]</xref><xref ref-type="bibr" rid="article-25496.r34">[34]</xref></p>
      </sec>
      <sec id="article-25496.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The CTG expansions of DM affect multiple organ systems in addition to the musculoskeletal system and is associated with several complications.</p>
        <p>
<bold>Central Nervous System</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Intellectual disabilities&#x000a0;can be seen in all types but are not universal for all types of DM. Most commonly seen in the congenital form of DM.</p>
          </list-item>
          <list-item>
            <p>Cerebrovascular accidents&#x000a0;can occur secondary&#x000a0;to DM associated atrial fibrillation.</p>
          </list-item>
          <list-item>
            <p>Anxiety and depression due to the loss of functional status</p>
          </list-item>
          <list-item>
            <p>Hypersomnia and sleep apnea are common due to sleep cycle dysfunctions.</p>
          </list-item>
          <list-item>
            <p>Ventriculomegaly is seen in congenital DM.</p>
          </list-item>
        </list>
        <p>
<bold>Ophthalmologic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cataracts are almost universal in all patients with DM and are seen early with typical onset in the &#x02019;40s. Hyperopia and astigmatism&#x000a0;can also occur.</p>
          </list-item>
        </list>
        <p>
<bold>Cardiac</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>More than 50% of patients experience cardiac abnormalities with DM,&#x000a0;and they&#x000a0;can occur prior to the onset of neuromuscular symptoms.<xref ref-type="bibr" rid="article-25496.r23">[23]</xref><xref ref-type="bibr" rid="article-25496.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Common cardiac complications include:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Atrial arrhythmias, conduction system slowing, ventricular arrhythmias, cardiomyopathy, and early-onset heart failure.</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>
<bold>Pulmonary</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pneumonia&#x000a0;is common due to progressive loss of lung function and reduced lung volumes as a result of progressive neuromuscular-associated respiratory failure.</p>
          </list-item>
          <list-item>
            <p>Increased risk of anesthesia-related pulmonary complications<xref ref-type="bibr" rid="article-25496.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Gastrointestinal</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Facial diplegia and oropharyngeal dysphagia can result in dysphagia and an increased risk of aspiration.</p>
          </list-item>
          <list-item>
            <p>There is also an increased incidence of gallstones and cholecystitis due to a hypertonic gallbladder sphincter.</p>
          </list-item>
          <list-item>
            <p>Transaminitis and liver enzyme elevations are seen for unknown reasons.</p>
          </list-item>
          <list-item>
            <p>Increased risk of post anesthesia aspiration due to the weakness of pharyngeal musculature.<xref ref-type="bibr" rid="article-25496.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Endocrine</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Insulin insensitivity can be seen</p>
          </list-item>
          <list-item>
            <p>The loss of the seminiferous tubules results and testicular atrophy&#x000a0;results in male infertility.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>In women, there is an increased risk of abortion, miscarriage, pre-term birth rates, and dysmenorrhea.</p>
          </list-item>
        </list>
        <p>
<bold>Dermatologic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Androgenic alopecia with frontal balding and increased risk of basal cell carcinoma and&#x000a0;pilomatrixomas.<xref ref-type="bibr" rid="article-25496.r37">[37]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Musculoskeletal</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>There is a progressive loss of motor function with increased wheelchair dependency towards the end of life.</p>
          </list-item>
          <list-item>
            <p>Impairments in activities of daily living (ADLs) due to distal muscle weakness of the hands and ankle dorsiflexors.</p>
          </list-item>
          <list-item>
            <p>Myalgias are very commonly noted.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25496.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>
<bold>Neurology and Physical Medicine and Rehabilitation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Oversee the patient&#x02019;s non-primary medical care and help direct and coordinate care and needs</p>
          </list-item>
          <list-item>
            <p>Should evaluate the patient annually for swallowing difficulties and functional mobility and durable medical equipment (DME) needs</p>
          </list-item>
          <list-item>
            <p>Assess if therapy is required to improve functional mobility</p>
          </list-item>
          <list-item>
            <p>Medications to help treat myotonia and pain</p>
          </list-item>
          <list-item>
            <p>Electrodiagnostic testing if indicated</p>
          </list-item>
        </list>
        <p>
<bold>Cardiology</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Indicated for those with cardiac symptoms, an abnormal annual 12-lead ECG, or those without a previous cardiac evaluation who are older than 40 years of age.<xref ref-type="bibr" rid="article-25496.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Due to the high incidence of cardiac involvement, cardiology referral should be considered as part of the routine multidisciplinary treatment.</p>
          </list-item>
        </list>
        <p>
<bold>Pulmonology</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Symptoms of respiratory insufficiency, recurrent pulmonary infections, or less than 50% of predicted FVC</p>
          </list-item>
        </list>
        <p>
<bold>Ophthalmology</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Annual eye exam that includes a slit-lamp examination</p>
          </list-item>
        </list>
        <p>
<bold>High-Risk Obstetrics and Gynecology</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Indicated for those pregnant or considering pregnancy due to miscarriage, preterm delivery, and respiratory difficulties during pregnancy</p>
          </list-item>
        </list>
        <p>
<bold>Genetic Counseling</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Indicated for those with a diagnosis of myotonic dystrophy and considering procreation</p>
          </list-item>
        </list>
        <p>
<bold>Physical, Occupational Therapy, and Speech-Language Pathology (SLP)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Indicated for impaired function, DME evaluation, and myalgias and chronic pain</p>
          </list-item>
          <list-item>
            <p>SLP is indicated for concerns for dysphagia or dysarthria</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25496.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated on the importance of maintaining strength and coping strategies to mitigate myotonic episodes. Education should also be performed to counsel individuals with DM on fertility strategies (if male) and the inheritance pattern of DM for those wishing to have children.</p>
      </sec>
      <sec id="article-25496.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The optimal management of patients with myotonic dystrophy requires an interprofessional approach. Members of the team should include a primary care provider or pediatrician if onset is before 18 years of age, a neurologist, and a physiatrist. Supplementary medical providers may include a cardiologist or ophthalmologist for associated cardiac arrhythmias or early-onset cataracts, respectively. Appropriate consultants should be involved whenever necessary to manage and treat these patients optimally. Other team members include physical therapists, occupational therapists, and speech-language pathologists to optimize function and assist with durable medical equipment evaluation. For pediatric patients, providing a structured and educational environment that is adapted to the intellectual disability with home health service staff well versed in neuroscience and rehabilitation is necessary. Unfortunately, at this time, there is no cure for DM, and treatment is aimed at monitoring and&#x000a0;treating&#x000a0;associated&#x000a0;conditions while maximizing functional independence.&#x000a0; Consensus-based care recommendations for adults with myotonic dystrophy type 1 and 2 should be followed to reduce morbidity and mortality.<xref ref-type="bibr" rid="article-25496.r24">[24]</xref><xref ref-type="bibr" rid="article-25496.r8">[8]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-25496.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25496&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25496">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/myotonic-dystrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25496">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25496/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25496">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25496.s17">
        <title>References</title>
        <ref id="article-25496.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Salajegheh</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Myotonic disorders: A review article.</article-title>
            <source>Iran J Neurol</source>
            <year>2016</year>
            <month>Jan</month>
            <day>05</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-53</page-range>
            <pub-id pub-id-type="pmid">27141276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brook</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>McCurrach</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Harley</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Buckler</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aburatani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stanton</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Thirion</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.</article-title>
            <source>Cell</source>
            <year>1992</year>
            <month>Feb</month>
            <day>21</day>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>799</fpage>
            <page-range>799-808</page-range>
            <pub-id pub-id-type="pmid">1310900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ranum</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Benzow</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Koob</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Genetic mapping of a second myotonic dystrophy locus.</article-title>
            <source>Nat Genet</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-8</page-range>
            <pub-id pub-id-type="pmid">9620781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thornton</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy.</article-title>
            <source>Neurol Clin</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>705</fpage>
            <page-range>705-19, viii</page-range>
            <pub-id pub-id-type="pmid">25037086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahadevan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsilfidis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sabourin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shutler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neville</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Narang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barcel&#x000f3;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Hoy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.</article-title>
            <source>Science</source>
            <year>1992</year>
            <month>Mar</month>
            <day>06</day>
            <volume>255</volume>
            <issue>5049</issue>
            <fpage>1253</fpage>
            <page-range>1253-5</page-range>
            <pub-id pub-id-type="pmid">1546325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hilton-Jones</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The myotonic dystrophies: diagnosis and management.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>358</fpage>
            <page-range>358-67</page-range>
            <pub-id pub-id-type="pmid">20176601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yotova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Labuda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zietkiewicz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gehl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lovell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lefebvre</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bourgeois</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lemieux-Blanchard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Labuda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>V&#x000e9;zina</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Houde</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tremblay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toupance</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heyer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Laberge</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec.</article-title>
            <source>Hum Genet</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>117</volume>
            <issue>2-3</issue>
            <fpage>177</fpage>
            <page-range>177-87</page-range>
            <pub-id pub-id-type="pmid">15883838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Montagnese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bassez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fossati</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gamez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heatwole</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hilbert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kornblum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kostera-Pruszczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krahe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lusakowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thornton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Udd</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Formaker</surname>
                <given-names>P</given-names>
              </name>
              <collab>Myotonic Dystrophy Foundation</collab>
            </person-group>
            <article-title>Consensus-based care recommendations for adults with myotonic dystrophy type 2.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-353</page-range>
            <pub-id pub-id-type="pmid">31583190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Impey</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>284</fpage>
            <page-range>284-8</page-range>
            <pub-id pub-id-type="pmid">17238150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Echenne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bassez</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Congenital and infantile myotonic dystrophy.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>113</volume>
            <fpage>1387</fpage>
            <page-range>1387-93</page-range>
            <pub-id pub-id-type="pmid">23622362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Logigian</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Blood</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Dilek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Wiegner</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Thornton</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.</article-title>
            <source>Muscle Nerve</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">15880468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenninger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Montagnese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Core Clinical Phenotypes in Myotonic Dystrophies.</article-title>
            <source>Front Neurol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>303</fpage>
            <pub-id pub-id-type="pmid">29770119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Callus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bertoldo</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Beretta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boveri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cardani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fossati</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brigonzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.</article-title>
            <source>Front Neurol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>751</fpage>
            <pub-id pub-id-type="pmid">30298045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cardani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.</article-title>
            <source>J Neuromuscul Dis</source>
            <year>2015</year>
            <month>Jul</month>
            <day>22</day>
            <volume>2</volume>
            <issue>s2</issue>
            <fpage>S59</fpage>
            <page-range>S59-S71</page-range>
            <pub-id pub-id-type="pmid">27858759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ricker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lehmann-Horn</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pongratz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heine</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts.</article-title>
            <source>Neurology</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>44</volume>
            <issue>8</issue>
            <fpage>1448</fpage>
            <page-range>1448-52</page-range>
            <pub-id pub-id-type="pmid">8058147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auvinen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suominen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hannonen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bachinski</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Krahe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Udd</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia.</article-title>
            <source>Arthritis Rheum</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>58</volume>
            <issue>11</issue>
            <fpage>3627</fpage>
            <page-range>3627-31</page-range>
            <pub-id pub-id-type="pmid">18975316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Myotonic Dystrophy Type 2</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2006</year>
            <month>9</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">20301639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achiron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barak</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Magal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shohat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gadoth</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Abnormal liver test results in myotonic dystrophy.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>292</fpage>
            <page-range>292-5</page-range>
            <pub-id pub-id-type="pmid">9649014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khoshbakht</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Soltanzadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zamani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Abdi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gharagozli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kahrizi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Khoshbakht</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nafissi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Correlation between distribution of muscle weakness, electrophysiological findings and CTG expansion in myotonic dystrophy.</article-title>
            <source>J Clin Neurosci</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>1123</fpage>
            <page-range>1123-6</page-range>
            <pub-id pub-id-type="pmid">24417793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nojszewska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lusakowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gawel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sierdzinski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sulek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krysa</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Elert-Dobkowska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Seroka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaminska</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kostera-Pruszczyk</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The needle EMG findings in myotonia congenita.</article-title>
            <source>J Electromyogr Kinesiol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>49</volume>
            <fpage>102362</fpage>
            <pub-id pub-id-type="pmid">31610484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burakgazi</surname>
                <given-names>AZ</given-names>
              </name>
            </person-group>
            <article-title>Electrodiagnostic findings in myotonic dystrophy: A study on 12 patients.</article-title>
            <source>Neurol Int</source>
            <year>2019</year>
            <month>Nov</month>
            <day>29</day>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>8205</fpage>
            <pub-id pub-id-type="pmid">31871599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pongratz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Koppenwallner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>H&#x000fc;bner</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Diagnostic value of muscle biopsy findings in myotonic dystrophy (Curschmann-Steinert) (author's transl)].</article-title>
            <source>Klin Wochenschr</source>
            <year>1979</year>
            <month>Mar</month>
            <day>01</day>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>215</fpage>
            <page-range>215-24</page-range>
            <pub-id pub-id-type="pmid">431031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNally</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bhakta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tomaselli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nazarian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Tamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Duboc</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hellerstein</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mammen</surname>
                <given-names>PPA</given-names>
              </name>
            </person-group>
            <article-title>Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2020</year>
            <month>Feb</month>
            <day>18</day>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>e014006</fpage>
            <pub-id pub-id-type="pmid">32067592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashizawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gagnon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Angeard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bassez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Berggren</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Bhakta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bozzali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>JLB</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cup</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>De Mattia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Duboc</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Duong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eichinger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ekstrom</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>van Engelen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Esparis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eymard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ferschl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gadalla</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gallais</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goodglick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heatwole</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hilbert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kierkegaard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koopman</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Maas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mankodi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Monckton</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nazarian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phetteplace</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Puymirat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Richer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sansone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Statland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Subramony</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trujillo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tomaselli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Venance</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winblad</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Consensus-based care recommendations for adults with myotonic dystrophy type 1.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>507</fpage>
            <page-range>507-520</page-range>
            <pub-id pub-id-type="pmid">30588381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arikawa-Hirasawa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Nishino</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nonaka</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Francomano</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Govindraj</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hassell</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Devaney</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Spranger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Iannaccone</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dalakas</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.</article-title>
            <source>Am J Hum Genet</source>
            <year>2002</year>
            <month>May</month>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>1368</fpage>
            <page-range>1368-75</page-range>
            <pub-id pub-id-type="pmid">11941538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charles</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lehmann-Horn</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jurkat-Rott</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Levitt</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals.</article-title>
            <source>J Neurol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>260</volume>
            <issue>10</issue>
            <fpage>2606</fpage>
            <page-range>2606-13</page-range>
            <pub-id pub-id-type="pmid">23884711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis of myotonic disorders.</article-title>
            <source>Muscle Nerve</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>293</fpage>
            <page-range>293-9</page-range>
            <pub-id pub-id-type="pmid">18067134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Skuse</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Lethlean</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>An analysis of myotonia in paramyotonia congenita.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1974</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>900</fpage>
            <page-range>900-6</page-range>
            <pub-id pub-id-type="pmid">4422263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d8;rstavik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Torbergsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Abicht</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erik Tangsrud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kerty</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A de novo Mutation in the SCN4A Gene Causing Sodium Channel Myotonia.</article-title>
            <source>J Neuromuscul Dis</source>
            <year>2015</year>
            <month>Jun</month>
            <day>04</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>181</fpage>
            <page-range>181-184</page-range>
            <pub-id pub-id-type="pmid">27858731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Luan</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Myotonia congenita: novel mutations in CLCN1 gene.</article-title>
            <source>Channels (Austin)</source>
            <year>2015</year>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>292</fpage>
            <page-range>292-8</page-range>
            <pub-id pub-id-type="pmid">26260254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Groh</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Monckton</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Bodkin</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Pascuzzi</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Survival and CTG repeat expansion in adults with myotonic dystrophy type 1.</article-title>
            <source>Muscle Nerve</source>
            <year>2011</year>
            <month>May</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>648</fpage>
            <page-range>648-51</page-range>
            <pub-id pub-id-type="pmid">21484823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Die-Smulders</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>H&#x000f6;weler</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Thijs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mirandolle</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Anten</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Smeets</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Geraedts</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Age and causes of death in adult-onset myotonic dystrophy.</article-title>
            <source>Brain</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>121 ( Pt 8)</volume>
            <fpage>1557</fpage>
            <page-range>1557-63</page-range>
            <pub-id pub-id-type="pmid">9712016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benhayon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lugo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carballeira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Elman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Long-term arrhythmia follow-up of patients with myotonic dystrophy.</article-title>
            <source>J Cardiovasc Electrophysiol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>305</fpage>
            <page-range>305-10</page-range>
            <pub-id pub-id-type="pmid">25546341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaudhry</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Frishman</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophies and the heart.</article-title>
            <source>Cardiol Rev</source>
            <year>2012</year>
            <season>Jan-Feb</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">22143278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ahtarovski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Vejlstrup</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vissing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Witting</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>K&#x000f8;ber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bundgaard</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.</article-title>
            <source>J Cardiovasc Magn Reson</source>
            <year>2014</year>
            <month>Aug</month>
            <day>01</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <pub-id pub-id-type="pmid">25086734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>N Saxena</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumar Panda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy: an anaesthetic dilemma.</article-title>
            <source>Indian J Anaesth</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>688</fpage>
            <page-range>688-91</page-range>
            <pub-id pub-id-type="pmid">20640098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25496.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Alsaggaf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meeraus</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Bremer</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Nikolenko</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lochmuller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Gadalla</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.</article-title>
            <source>Int J Cancer</source>
            <year>2018</year>
            <month>Mar</month>
            <day>15</day>
            <volume>142</volume>
            <issue>6</issue>
            <fpage>1174</fpage>
            <page-range>1174-1181</page-range>
            <pub-id pub-id-type="pmid">29114849</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
